Enhancing Diagnostic Precision with AI
Bracco Launches AiMIFY AI Software in the EU
New tool doubles contrast effect in brain MRI scans without increasing gadolinium dosage at ECR 2026.
A medical monitor in a radiology suite displaying a side-by-side comparison of brain MRI scans, demonstrating the contrast enhancement provided by AI software.
Photo: Avantgarde News
Bracco Imaging announced the European Union commercial launch of AiMIFY at the European Congress of Radiology (ECR) 2026 [1][2]. Developed in partnership with Subtle Medical, the AI-powered software is designed to amplify contrast enhancement during brain MRI examinations [1][3]. The tool specifically assists neuroradiologists in detecting small lesions with greater confidence [1]. The software functions by doubling the perceived contrast effect for clinicians [1]. This technological advancement allows for improved diagnostic imaging without requiring an increase in the dosage of gadolinium-based contrast agents [1][3]. In addition to this launch, Bracco expanded its digital health portfolio through a new partnership with Avicenna.AI [1].
Editorial notes
Transparency note
Drafted with LLM; human-edited
- AI assisted
- Yes
- Human review
- Yes
- Last updated
Risk assessment
Reviewed for sourcing quality and editorial consistency.
Sources
- 1.↗
prnewswire.com
https://www.prnewswire.com/news-releases/bracco-announces-eu-launch-of-aimify-and-expands-ai-portfolio-with-avicennaai-partnership-at-ecr-2026-302700528.html
- 2.↗
bracco.com
https://www.bracco.com/article/bracco-and-european-society-radiology-empower-future-radiology-ecr-2026
- 3.↗
subtlemedical.com
https://subtlemedical.com/bracco-diagnostics-and-subtle-medical-announce-fda-clearance-of-aimify-software/
Related stories
View all
Topics
About the author
Avantgarde News Desk covers enhancing diagnostic precision with ai and editorial analysis for Avantgarde News.